## ARE: Alexandria Real Estate Equities, Inc. - XLRE: Real Estate

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 9.5% in upper entry zone (4.0-10.0%), top 6% cross-sectional ranking. Short-term MRS_5 (4.6%) confirms momentum alignment. Strong momentum (+6.1% 5-day acceleration). Outperforming sector by 9.4%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($49.23)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 2, Bearish: 7)

**1. Alexandria Real Estate Equities Inc. stock outperforms competitors on strong trading day**
- Source: MarketWatch | 20260106T163000 | Bullish | Relevance: 100%
- Alexandria Real Estate Equities Inc. (ARE) experienced a strong trading day, with its stock rising 5.73% to $52.38. This performance outpaced the broader market, as the S&P 500 Index and Dow Jones Industrial Average also saw gains. This marked the third consecutive day of gains for the company's stock.

**2. ARE Investors Have Opportunity to Lead Alexandria Real Estate Equities, Inc. Securities Fraud Lawsuit with the Schall Law Firm**
- Source: GlobeNewswire | 20260106T093000 | Bearish | Relevance: 100%
- The Schall Law Firm is reminding investors of a class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE) for alleged securities fraud. The lawsuit claims the company made false and misleading statements regarding leasing spreads and anticipated occupancy growth for its life-science properties between January 27, 2025, and October 27, 2025. Investors who suffered losses during this period are encouraged to contact the firm before January 26, 2026, to participate in the lawsuit.

**3. Deadline Alert: Alexandria Real Estate Equities, Inc. (ARE)**
- Source: GlobeNewswire | 20260105T190802 | Bearish | Relevance: 100%
- Glancy Prongay & Murray LLP reminds investors of Alexandria Real Estate Equities, Inc. (ARE) about an upcoming January 26, 2026 deadline to file a lead plaintiff motion in a class action lawsuit. This lawsuit alleges that Alexandria made materially false and misleading statements regarding its Long Island City property's value and growth prospects, leading to a significant stock price drop after a real estate impairment charge was disclosed. Investors who suffered losses on their Alexandria investments during the Class Period (January 27, 2025, to October 27, 2025) are urged to contact the firm.

**4. SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Alexandria Real Estate Equities, Inc. (NYSE: ARE)**
- Source: GlobeNewswire | 20260105T140756 | Bearish | Relevance: 100%
- Bernstein Liebhard LLP has announced the filing of a securities class action lawsuit against Alexandria Real Estate Equities, Inc. (NYSE: ARE) on behalf of investors who purchased shares between January 27, 2025, and October 27, 2025. The lawsuit alleges that the company made misrepresentations regarding its Long Island City property. Shareholders who wish to serve as lead plaintiff must file papers by January 26, 2026.

**5. Alexandria Real Estate Equities, Inc. Celebrates 32 Years of Pioneering Leadership in Life Science Real Estate and Consequential Impact on Advancing Human Health**
- Source: PR Newswire | 20260105T130735 | Bullish | Relevance: 100%
- Alexandria Real Estate Equities, Inc. (NYSE: ARE) is celebrating 32 years as a leader in life science real estate, pioneering Megacampus ecosystems in key innovation clusters. The company's persistent leadership has been critical in advancing human health through mission-critical infrastructure and fostering collaborations that accelerate life science innovation, even amidst challenging market conditions. Alexandriaâ€™s robust asset base and strong tenant retention highlight its pivotal role in the discovery of groundbreaking therapies and cures, exemplified by its efforts in addressing major depressive disorder.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Jefferies | $47 | $62 | -24% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Jefferies | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 6 ($0.14M) |
| Sells | 15 ($4.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Vanguard Group Inc: 14.9% (-1.1%)
- Blackrock Inc.: 10.0% (-10.7%)
- State Street Corpora: 6.5% (+3.7%)
- Apg Asset Management: 3.9% (0.0%)
- JPMORGAN CHASE & CO: 3.3% (+34.1%)

### Key Risks

1. Insider selling cluster: $4.2M in recent transactions.
2. Valuation risk: PEG 844.2x with declining EPS estimates leaves no margin for error.
3. Long-term trend broken: trading 26.8% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +6.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 844.20 signals overvaluation risk, limited margin of safety. Revenue declining -8% YoY, concerning. Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($4.2M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $9.1B |
| Beta | 1.32 |
| 52W Range | $44.10 - $105.14 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 844.20 |
| Forward P/E | N/A |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 3.5% to 9.5% (+6.1% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 93rd percentile. MRS_5 at 4.6% confirms short-term momentum alignment. AM_20 at 10.4% shows strong absolute momentum above own 20MA. Outperforming sector by 9.4pp, stock-specific strength. Below SMA200 (0.73x), long-term trend not supportive. MACD histogram positive (0.84), confirming momentum. RSI neutral at 59. OFD pattern: +F0N (Breakout).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 9.54% (CS: 94) | Strong |
| RSI_14 | 59.4 | Neutral |
| MACD Histogram | 0.84 | Bullish |
| vs SMA20 | 1.092x | Above |
| vs SMA50 | 1.007x | Above |
| vs SMA200 | 0.732x | Below |

### Decision

- **Verdict:** HOLD
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $52.41
- **Stop Loss:** $49.23 (6.1% risk)
- **Target:** $57.18 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 345
- **Position Value:** $18,081.45
- **Portfolio %:** 18.08%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

**Next:** 2026-01-26 (Est: $0.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.50 | +28.2% |
| 2025Q2 | $0.63 | $0.48 | -24.0% |
| 2025Q1 | $0.60 | $0.51 | -15.5% |
| 2024Q4 | $0.90 | $0.69 | -23.0% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*